Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,059 public trials 1,846 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Active, not recruiting

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

NCT04044859

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +54 more
Locations
  • Name of Institution: Orlando Health Cancer Institute Orlando, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 17 locations
View Trial Details
Active, not recruiting

Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

NCT04685135

Conditions
Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations
  • Local Institution - 012-898 Cerritos, California, United States
  • Local Institution - 012-898 D Glendale, California, United States
  • Local Institution - 012-910-A Huntington Beach, California, United States
  • Local Institution - 012-910-C Irvine, California, United States
View all 380 locations
View Trial Details
Active, not recruiting

Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer

NCT03600701

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 18 locations
View Trial Details
Active, not recruiting

Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer

NCT06732401

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Cedars-Sinai Cancer - Tarzana Tarzana, California, United States
View all 192 locations
View Trial Details
Active, not recruiting

A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer

NCT03392246

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Duke University Durham, North Carolina, United States
View Trial Details
Active, not recruiting

ENCOrafenib With Binimetinib in bRAF NSCLC

NCT04526782

Conditions
BRAF V600E, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Annemasse - CH Ambilly, France
  • Angers - CHU Angers, France
  • Avignon - Institut Sainte-Catherine Avignon, France
  • Bordeaux - Institut Bergonié Bordeaux, France
View all 36 locations
View Trial Details

Related conditions